FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit_老虎社区_美港股上老虎

FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit

T-Reuters2021-07-17

July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Johnleong
·2021-07-17
Great
回复
点赞
举报
Johnleong
·2021-07-17
Great
回复
点赞
举报
Janiceng888
·2021-07-17
Good buy
回复
1
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2152068390?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-07-17 04:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2152068390","market":"us","top_or_hot":-1,"title":"FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit","media":"T-Reuters","content":"<html><body><p>July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-17 04:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.trkd.thomsonreuters.com><strong>T-Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of ...</p>\n\n<a href=\"https://www.trkd.thomsonreuters.com\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2152068390","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2152068390","pubTimestamp":1626467099,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nit","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"美国食品和药物管理局表示，不会反对在亚硝胺含量低于临时可接受摄入量的情况下分配香替克斯","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":179385588,"gmtCreate":1626486785244,"gmtModify":1631891504672,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179385588","repostId":2152068390,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":179385931,"gmtCreate":1626486763323,"gmtModify":1631891504687,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179385931","repostId":2152068390,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":179310641,"gmtCreate":1626485987383,"gmtModify":1633926353969,"author":{"id":"3578291442131612","authorId":"3578291442131612","name":"Janiceng888","avatar":"https://static.tigerbbs.com/838fe7c85e12c91189f834cf68df9b41","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3578291442131612","authorIdStr":"3578291442131612"},"htmlText":"Good buy","listText":"Good buy","text":"Good buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179310641","repostId":2152068390,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":2,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}